作者：国际循环网 发布于：2004-08-06
OBJECTIVE: To determine whether initial therapy with controlled-onset extended-release (COER) verapamil is equivalent to a physician’s choice of atenolol or hy...
BACKGROUND: Most cardiovascular events associated with hypertension are complications of atherosclerosis. Some antihypertensive agents influence experimental mo...
BACKGROUND: Despite treatment， there is often a higher incidence of cardiovascular complications in patients with hypertension than in normotensive individuals...
作者：HanssonL，ZanchettiA 发布于：2004-08-06
BACKGROUND: The efficacy of antihypertensive drugs newer than diuretics and beta-blockers has not been established. We compared the effects of the calcium-chann...
作者：BrownMJ，PalmerCR 发布于：2004-08-06
OBJECTIVE: Irbesartan is renoprotective in patients with type 2 diabetes and microalbuminuria. Whether the observed reduction in microalbuminuria is reversible ...
The Japan Multicenter Investigation for Cardiovascular Diseases-B was performed to investigate whether nifedipine retard treatment was associated with a signifi...
BACKGROUND: Blood pressure reduction achieved with beta-blockers and diuretics is the best recorded intervention to date for prevention of cardiovascular morbid...
BACKGROUND: Elevated urine albumin excretion (UAER) is a modifiable risk factor for renal and cardiovascular disease in type 2 diabetes. Blockade of the renin-a...
专家视角丨高血压管理新篇：余静教授202..
心房颤动患者和动脉粥样硬化患者磁共振..
ESC专访｜郭豫涛教授解析mAFA扩展试验结..
波兰国家注册数据：药物涂层球囊治疗冠..
京公网安备 11010502033353号 增值电信业务经营许可证:京ICP证150541号
